Obesity
Conditions
Brief summary
The study aims are 1. to demonstrate the feasibility of recruiting and enrolling 10 subjects aged 55-75 planning to undergo sleeve gastrectomy and enrolling 10-20 (1-2 per surgical patient) matched subjects to the described intensive lifestyle intervention. 2. to collect preliminary data on the comparative effectiveness of the two interventions on physical function, weight loss, body composition, bone density and QOL.
Detailed description
The investigators propose a 1-year pilot feasibility study to examine the comparative effectiveness of sleeve gastrectomy compared to an intensive lifestyle intervention of a high protein low carbohydrate, hypocaloric weight loss diet combined with exercise training among older adults aged 60-75. For pragmatic and ethical reasons, the investigators are employing a nonrandomized design. The investigators will recruit 10 older patients undergoing sleeve gastrectomy and match, recruit, and enroll 1-2 subjects to the lifestyle intervention for each surgical subject. The investigators will assess physical function, weight loss, body composition, bone density, QOL and adverse events/health utilization at baseline and 6 and 12 months.
Interventions
BEHAVIORALExercise program
Physical therapy for aerobic and resistance training exercises
DIETARY_SUPPLEMENTNutrition
Nutrition supplementation via HMR for lifestyle arm only
PROCEDUREWLS
Weight loss surgery as planned
Sponsors
Beth Israel Deaconess Medical Center
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patients must be aged 55-75 at the time of recruitment, * speak English, * meet medical eligibility criteria for WLS (i.e. BMI of \>40 or \>35 with a major obesity comorbidity), * and be willing and able to participate in study procedures including the physical activity intervention and complete follow-up.
Exclusion criteria
The investigators will exclude participants for whom * intentional weight loss might be inappropriate (e.g. patients with serious life-limiting illness) * or who might be psychologically unstable (e.g. moderate to severe depression on the PHQ-9) * or who have contraindications to a high protein diet or the physical activity intervention (e.g. recent MI/CVA in last 6 months, uncontrolled congestive heart failure, serum creatinine \> 2.0 mg/dl/on dialysis, h/o celiac disease/crohn's disease/ulcerative colitis.) * or patients whose weight exceeds 450 lbs (weight limit of DXA). * The investigators will withdraw bariatric subjects who do not undergo weight loss surgery and his or her matched lifestyle subject. The investigators will withdraw subjects in the lifestyle group who do not attend at least attend two of the first three nutrition and physical therapy visits. The investigators will recruit additional subjects to replace lifestyle subjects who are withdrawn from the study for this reason.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Physical Function | Years 1 and 2 | The primary outcome will be change in physical function as measured change in score on the Short Physical Performance Battery (SPPB) between the two groups at 6 months and 12 months. Secondary physical function outcomes includes change in performance on the Timed 400m walk and the sum of the one-repetition maximal weight subjects are able to lift in the biceps curl, bench press, seated row, knee extension and flexion, and leg press.\[ |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in medical history, medications and healthcare utilization from adverse events | Years 1 and 2 | all visits, hospitalizations, and emergency room visits including any study related visits. |
| Change in anthropometric measurements-body weight | Years 1 and 2 | Changes in: body weight |
| Change in anthropometric measurements-waist circumference | Years 1 and 2 | Changes in: waist circumference |
| Change in body composition | Years 1 and 2 | Change in: fat mass, lean body mass of the whole body |
| Change in bone mineral density | Years 1 and 2 | Change in: bone density at the total hip and radius as measured by dual energy x-ray absorptiometry (DEXA) among subjects who weigh up to 450 lbs (equipment weight limit) |
| Change in disability | Years 1 and 2 | Change in: difficulty performing ADLs and IADLs |
| Change in biochemical assessments-hbA1C | Years 1 and 2 | Change in: hemoglobin A1c, |
| Change in biochemical assessments-insulin and glucose | Years 1 and 2 | Change in: insulin and fasting glucose (insulin resistance) |
| Change in biochemical assessments-bone and muscle metabolism | Years 1 and 2 | Change in: biomarkers related to bone and muscle metabolism including vitamin D and bone alkaline phosphatase |
| Change in quality of life | Years 1 and 2 | Change in: Quality of life scores as measured by the Impact of Weight on Quality of Life and the Short Form-36 |
| Change in pain | Years 1 and 2 | Change in: pain score using the Brief Pain Inventory |
| Change in blood pressure | Years 1 and 2 | Change in: blood pressure |
Countries
United States
Outcome results
None listed